Aurex outlicenses pharmaceutical products to companies throughout the world. We offer a large range of generic products to our clients and we offer the benefits of vertically integrated manufacturing.
Our portfolio covers many therapeutic areas, such as CNS, gastro and cardio-vascular. We have a very robust range of anti-infectives including antiretrovirals. We supply solid orals, as well as powders for solution, ophthalmics and a wide range of injectable products. Our in-house developed regulatory dossiers are state of the art and comply with latest EU and global regulatory standards.
Manufacturing of intermediates, API’s and finished dosage forms all takes place in our own production sites. This vertical integration offers advantages regarding costs, quality and supply chain to our clients. Our manufacturing facilities have been inspected and approved by all major regulatory authorities in the world.
Aurex is a subsidiary of Aurobindo Pharma Ltd, a vertically integrated pharma multinational and Aurex uses Aurobindo’s R&D and manufacturing facilities. Please visit www.aurobindo.com